Brief: HUTCHMED (China) Announces NMPA Conditional Approval For Orpathys For Met-Amplified Advanced Gastric Cancer In China
BRIEF-HUTCHMED (China) Announces NMPA Conditional Approval For Orpathys For Met-Amplified Advanced Gastric Cancer In China July 2 (Reuters) - HUTCHMED (China) Ltd 0013.HK:
ANNOUNCES NMPA CONDITIONAL APPROVAL FOR ORPATHYS FOR MET-AMPLIFIED ADVANCED GASTRIC CANCER IN CHINA
Further company coverage: 0013.HK
((Reuters.Briefs@thomsonreuters.com;))